|
PRCC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50815999999665E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02339999977319E-07 |
| Normal-vs-Stage2 |
3.07800000043379E-07 |
| Normal-vs-Stage3 |
9.071600E-01 |
| Normal-vs-Stage4 |
5.646000E-01 |
| Stage1-vs-Stage2 |
3.209600E-01 |
| Stage1-vs-Stage3 |
5.422900E-03 |
| Stage1-vs-Stage4 |
2.246300E-02 |
| Stage2-vs-Stage3 |
2.115800E-03 |
| Stage2-vs-Stage4 |
6.936300E-02 |
| Stage3-vs-Stage4 |
6.960200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.61220000003149E-06 |
| Normal-vs-AfricanAmerican |
4.39030000000118E-05 |
| Normal-vs-Asian |
1.997590E-02 |
| Caucasian-vs-AfricanAmerican |
8.531200E-01 |
| Caucasian-vs-Asian |
8.687200E-01 |
| AfricanAmerican-vs-Asian |
7.637800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48409999956023E-07 |
| Normal-vs-Female |
1.484030E-01 |
| Male-vs-Female |
6.377300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.164000E-03 |
| Normal-vs-Extreme_Weight |
1.29589999953161E-07 |
| Normal-vs-Obese |
5.055100E-03 |
| Normal-vs-Extreme_Obese |
1.408400E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.573500E-02 |
| Normal_Weight-vs-Obese |
6.768200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.933160E-01 |
| Extreme_Weight-vs-Obese |
1.467680E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.090400E-01 |
| Obese-vs-Extreme_Obese |
1.416970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.225400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.774260E-04 |
| Normal-vs-Age(61-80Yrs) |
5.97270000013417E-07 |
| Normal-vs-Age(81-100Yrs) |
1.2502999999775E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.572490E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.039600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.216200E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.938000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.672340E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.300350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.32709999995018E-06 |
| Normal-VS-Type2 PRCC |
1.76789999999372E-05 |
| Normal-VS-KIRP CIMP |
2.367800E-01 |
| Normal-VS-Unclassified PRCC |
1.563870E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.507400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.797120E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.215400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.855420E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.857000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.707700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.72229999840479E-08 |
| Normal-vs-N1 |
3.164200E-01 |
| Normal-vs-N2 |
3.353800E-01 |
| N0-vs-N1 |
1.715320E-03 |
| N0-vs-N2 |
1.321090E-03 |
| N1-vs-N2 |
9.939200E-01 |
|
|
